INVO Fertility, Inc. (IVF) Financial Ratios
19 years of historical data (2006–2024) · Healthcare · Medical - Devices
EV/EBITDA
N/A
—
5yr avg: N/A
P/FCF
N/A
—
5yr avg: N/A
P/B Ratio
↓
0.01
↓-100% vs avg
5yr avg: 3447.98
30Y Low3.9·High79.9
ROE
↑
-133.4%
↓+71% vs avg
5yr avg: -460.4%
30Y Low-344%·High-20%
Debt/EBITDA
N/A
—
5yr avg: N/A
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
IVF Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
INVO Fertility, Inc. currently has a negative P/E ratio, indicating the company is operating at a loss on a trailing-twelve-month basis.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $3M | $50M | $32M | $85M | $584M | $78.5B | $53.5B | $102.6B | $34.9B | $77.9B | $152.0B |
| Enterprise Value | $12M | $59M | $38M | $87M | $580M | $78.5B | $53.5B | $102.6B | $34.9B | $77.9B | $152.0B |
| P/E Ratio → | -0.01 | — | — | — | — | — | — | — | — | — | — |
| P/S Ratio | 0.40 | 7.60 | 10.55 | 103.12 | 140.37 | 75699.79 | 36165.12 | 207631.36 | 123642.30 | 1531123.40 | 13003711.09 |
| P/B Ratio | 0.01 | 3.89 | 35.70 | — | 79.87 | 13672.45 | — | — | — | — | — |
| P/FCF | — | — | — | — | — | — | 40999.70 | — | — | — | — |
| P/OCF | — | — | — | — | — | — | 39059.88 | — | — | — | — |
P/E links to full P/E history page with 30-year chart
IVF EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 9.00 | 12.56 | 105.77 | 139.51 | 75690.81 | 36164.59 | 207631.73 | 123643.42 | 1531127.33 | 13003687.89 |
| EV / EBITDA | — | — | — | — | — | — | — | — | — | — | — |
| EV / EBIT | — | — | — | — | — | — | — | — | — | — | — |
| EV / FCF | — | — | — | — | — | — | 40999.10 | — | — | — | — |
IVF Profitability
Margins and return-on-capital ratios measuring operating efficiency
INVO Fertility, Inc. earns an operating margin of -124.4%. Operating margins have expanded from -1292.5% to -124.4% over the past 3 years, signaling improving operational efficiency. A negative ROE of -133.4% indicates the company is currently destroying shareholder equity.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 44.0% | 44.0% | 36.0% | -3.5% | 96.5% | 91.4% | 90.6% | 81.7% | 81.6% | 70.3% | 33.2% |
| Operating Margin | -124.4% | -124.4% | -224.0% | -1292.5% | -125.4% | -531.7% | -120.8% | -532.8% | -227.0% | -4146.1% | -5090.9% |
| Net Profit Margin | -139.3% | -139.3% | -266.0% | -1324.8% | -160.0% | -804.7% | -146.4% | -622.2% | -248.9% | -4173.3% | -42426.6% |
Return on Capital
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -133.4% | -133.4% | -899.9% | -344.0% | -102.0% | -822.6% | — | — | — | — | — |
| ROA | -28.0% | -28.0% | -72.3% | -153.7% | -62.2% | -131.0% | -168.5% | -589.4% | -254.1% | -490.6% | -1442.0% |
| ROIC | -42.2% | -42.2% | -124.3% | -321.9% | -4610.2% | — | — | — | — | — | — |
| ROCE | -41.6% | -41.6% | -124.5% | -221.7% | -58.4% | -123.2% | -607.4% | — | — | — | — |
IVF Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
Net debt stands at $9M ($10M total debt minus $741396 cash).
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.78 | 0.78 | 7.06 | — | 0.29 | 0.13 | — | — | — | — | — |
| Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | — |
| Net Debt / Equity | — | 0.72 | 6.80 | — | -0.49 | -1.62 | — | — | — | — | — |
| Net Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | — |
| Debt / FCF | — | — | — | — | — | — | -0.60 | — | — | — | — |
| Interest Coverage | -7.63 | -7.63 | -7.65 | -182.19 | -4.26 | -1.94 | -4.72 | -5.96 | -32.64 | -152.51 | -153.89 |
IVF Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
The current ratio of 0.07x is below 1.0, meaning current liabilities exceed current assets. The current ratio has declined from 0.19x to 0.07x over the past 3 years.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.07 | 0.07 | 0.16 | 0.19 | 5.03 | 4.61 | 1.03 | 0.21 | 0.05 | 0.05 | 0.13 |
| Quick Ratio | 0.06 | 0.06 | 0.12 | 0.11 | 4.80 | 4.49 | 0.96 | 0.20 | 0.03 | 0.03 | 0.11 |
| Cash Ratio | 0.04 | 0.04 | 0.03 | 0.03 | 4.54 | 4.41 | 0.83 | 0.06 | 0.01 | 0.03 | 0.11 |
| Asset Turnover | — | 0.14 | 0.16 | 0.22 | 0.40 | 0.09 | 0.82 | 0.64 | 1.06 | 0.18 | 0.02 |
| Inventory Turnover | 16.64 | 16.64 | 7.31 | 3.23 | 0.50 | 0.33 | 1.38 | 2.08 | 0.88 | 0.18 | 0.12 |
| Days Sales Outstanding | — | 9.77 | 16.98 | 34.25 | 4.43 | 7.64 | 1.86 | 166.78 | 112.16 | 20.04 | 42.03 |
IVF Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
INVO Fertility, Inc. does not currently pay a dividend and has no material buyback yield, reinvesting earnings back into the business.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — | — | — |
Total Shareholder Return Metrics
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | — | — | — | — | — | — | — |
| FCF Yield | — | — | — | — | — | — | 0.0% | — | — | — | — |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Total Shareholder Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Shares Outstanding | — | $42560 | $16398 | $6943 | $6089 | $905804 | $806002 | $795571 | $732867 | $724951 | $706847 |
Peer Comparison
Compare IVF with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 IVFYou | $3M | -0.0 | — | — | 44.0% | -124.4% | -133.4% | -42.2% | — |
 NTRA | $31B | -144.6 | — | 285.5 | 64.8% | -13.4% | -14.3% | -36.1% | — |
 PGNY | $2B | 29.5 | 16.4 | 8.2 | 23.6% | 6.6% | 12.5% | 18.1% | 0.3 |
 INMD | $882M | 9.7 | 6.9 | 10.5 | 78.5% | 23.0% | 13.5% | 13.5% | 0.2 |
 MARA | $5B | -3.4 | — | — | -47.7% | -90.6% | -34.5% | -9.0% | — |
 HOLX | $17B | 30.5 | 17.4 | 18.4 | 61.0% | 17.4% | 11.1% | 9.4% | 2.6 |
 QDEL | $733M | -0.6 | — | — | 46.7% | -33.7% | -46.1% | -13.6% | — |
 TNDM | $1B | -6.1 | — | — | 52.3% | -7.7% | -97.9% | -10.0% | — |
 LH | $21B | 24.7 | 12.7 | 17.6 | 26.8% | 10.9% | 10.5% | 7.8% | 3.3 |
 DGX | $21B | 21.8 | 12.7 | 15.5 | 31.9% | 14.5% | 14.0% | 8.8% | 3.2 |
 EXAS | $20B | -95.4 | — | 56.1 | 69.7% | -6.4% | -8.7% | -3.6% | — |
| Healthcare Median | — | 22.3 | 14.5 | 18.5 | 64.0% | -5.2% | -33.7% | -11.2% | 3.3 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 19 years · Updated daily
See IVF's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs IVF Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare IVF vs NTRA
Side-by-side business, growth, and profitability comparison vs Natera, Inc..
Start ComparisonIVF — Frequently Asked Questions
Quick answers to the most common questions about buying IVF stock.
What is INVO Fertility, Inc.'s P/E ratio?
INVO Fertility, Inc.'s current P/E ratio is -0.0x. This places it at the 50th percentile of its historical range.
What is INVO Fertility, Inc.'s ROE?
INVO Fertility, Inc.'s return on equity (ROE) is -133.4%. The historical average is -149.7%.
Is IVF stock overvalued?
Based on historical data, INVO Fertility, Inc. is trading at a P/E of -0.0x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
What are INVO Fertility, Inc.'s profit margins?
INVO Fertility, Inc. has 44.0% gross margin and -124.4% operating margin.